Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM. Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease. Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Review. PubMed PMID: 23040292.
AÑO: 2013; IF: 2.979
|
Heman P, Barcia C, Gómez A, Ros CM, Ros-Bernal F, Yuste JE, de Pablos V, Fernandez-Villalba E, Toledo-Cárdenas MR, Herrero MT. Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys. Histol Histopathol. 2012 Jan;27(1):89-94. PubMed PMID: 22127600.
AÑO: 2012; IF: 2.281
|
Sánchez-Pérez AM, Claramonte-Clausell B, Sánchez-Andrés JV, Herrero MT. Parkinson's disease and autophagy. Parkinsons Dis. 2012;2012:429524. doi: 10.1155/2012/429524. Epub 2012 Oct 17. PubMed PMID: 23125941; PubMed Central PMCID: PMC3483737.
AÑO: 2012
|
Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Llera D, Martínez-Pagán ME, de Pablos V, Fernandez-Villalba E, Herrero MT. IFN-? signaling, with the synergistic contribution of TNF-?, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 2012 Aug 23;3:e379. doi: 10.1038/cddis.2012.123. PubMed PMID: 22914327; PubMed Central PMCID: PMC3434670.
AÑO: 2012; IF: 6.044
|
Yuste JE, Echeverry MB, Ros-Bernal F, Gomez A, Ros CM, Campuzano CM, Fernandez-Villalba E, Herrero MT. 7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease. Neuropharmacology. 2012 Dec;63(7):1258-67. doi: 10.1016/j.neuropharm.2012.07.031. Epub 2012 Aug 1. PubMed PMID: 22877786.
AÑO: 2012; IF: 4.114
|